Imunon, Inc. financial data

Symbol
IMNN on Nasdaq
Industry
Pharmaceutical Preparations
Location
997 Lenox Drive, Suite 100, Lawrenceville, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
CELSION CORP (to 9/19/2022), Celsion CORP (to 9/19/2022), CHEUNG LABORATORIES INC (to 2/17/1998)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 222 % -41.7%
Debt-to-equity 78.4 % +70.6%
Return On Equity -230 % -97.3%
Return On Assets -129 % -61.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.5M shares +54.3%
Common Stock, Shares, Outstanding 14.5M shares +54.8%
Entity Public Float 11.9M USD -9.16%
Common Stock, Value, Issued 145K USD +54.8%
Weighted Average Number of Shares Outstanding, Basic 14.4M shares +54.1%
Weighted Average Number of Shares Outstanding, Diluted 14.4M shares +54.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 500K USD 0%
Research and Development Expense 13M USD +20.7%
General and Administrative Expense 7.99M USD -29.7%
Operating Income (Loss) -21M USD +4.71%
Nonoperating Income (Expense) 222K USD -72.9%
Net Income (Loss) Attributable to Parent -19.5M USD +30.2%
Earnings Per Share, Basic -1.87 USD/shares +40.3%
Earnings Per Share, Diluted -1.87 USD/shares +8.11%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 10.3M USD -20%
Cash, Cash Equivalents, and Short-term Investments 10.3M USD -47.2%
Assets, Current 12.5M USD -42.3%
Other Long-term Investments 3.75M USD -37.5%
Deferred Income Tax Assets, Net 1.28M USD -18.3%
Property, Plant and Equipment, Net 564K USD -31.6%
Operating Lease, Right-of-Use Asset 1.25M USD -25.2%
Other Assets, Noncurrent 1.3M USD -38.5%
Assets 14.4M USD -41.6%
Accounts Payable, Current 3.52M USD -1.99%
Employee-related Liabilities, Current 1.46M USD +2.88%
Accrued Liabilities, Current 2.57M USD -14.8%
Contract with Customer, Liability, Current 125K USD -75%
Liabilities, Current 5.44M USD +2.36%
Operating Lease, Liability, Noncurrent 758K USD -40.2%
Liabilities 6.2M USD -5.82%
Accumulated Other Comprehensive Income (Loss), Net of Tax 133K USD +7.45%
Retained Earnings (Accumulated Deficit) -403M USD -5.08%
Stockholders' Equity Attributable to Parent 8.19M USD -54.7%
Liabilities and Equity 14.4M USD -41.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.87M USD -47.5%
Net Cash Provided by (Used in) Financing Activities 2.47M USD
Net Cash Provided by (Used in) Investing Activities 2.38M USD +472%
Common Stock, Shares Authorized 113M shares 0%
Common Stock, Shares, Issued 14.5M shares +54.8%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.49M USD -220%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.84M USD -66.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 180K USD -95.7%
Deferred Tax Assets, Valuation Allowance 73M USD -20.3%
Deferred Tax Assets, Gross 74.3M USD -20.2%
Operating Lease, Liability 1.27M USD -27.1%
Depreciation 70.3K USD +42%
Payments to Acquire Property, Plant, and Equipment 11.8K USD -79.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -19.4M USD +30.2%
Lessee, Operating Lease, Liability, to be Paid 1.46M USD -29.9%
Property, Plant and Equipment, Gross 2.85M USD -10.6%
Operating Lease, Liability, Current 508K USD +8.04%
Lessee, Operating Lease, Liability, to be Paid, Year Two 363K USD -33.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 543K USD -13.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Deferred Income Tax Expense (Benefit) 1.28M USD -18.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 198K USD -43.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 370K USD +2%
Deferred Tax Assets, Operating Loss Carryforwards 67.3M USD -15.7%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 100K shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 370K USD
Operating Lease, Payments 629K USD -3.77%
Additional Paid in Capital 411M USD +2.38%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 193K USD +10.7%
Deferred Tax Assets, Net of Valuation Allowance 1.28M USD -18.3%
Interest Expense 37.1K USD -64.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%